You are here

Merck

Merck Is Piloting A Drone Delivery Program For Medications

Forbes

Mon, 10/26/20 - 11:11 pm

KSQ boosts PARP inhibition in animal models of ovarian and breast cancers with USP1 inhibitor

Fierce Biotech

Sun, 10/25/20 - 11:28 pm

KSQ Therapeutics

PARP inhibitors

Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again

Fierce Biotech

Tue, 10/20/20 - 10:38 am

clinical trials

pneumococcal disease

Merck touts new data for Keytruda combos in NSCLC at North American conference

Endpoints

Mon, 10/19/20 - 10:47 am

clinical trials

non-small cell lung cancer

FDA approves expanded indication for Merck’s KEYTRUDA in adult patients with relapsed or refractory cHL

Pharmaceutical Business Review

Fri, 10/16/20 - 11:05 am

Hodgkin's lymphoma

Merck Plans New Facility to Triple Production of Life-Saving Bladder Cancer Drug

BioSpace

Thu, 10/15/20 - 10:15 pm

drug manufacturing

Merck CEO Ken Frazier Calls On Corporate America To Help Stabilize Society

Forbes

Wed, 10/14/20 - 09:03 pm

Sensei raises $29M to advance anti-cancer bacteriophage pipeline

Fierce Biotech

Fri, 10/9/20 - 11:05 am

Sensei Biotherapeutics

As Moderna doubles down on vaccines, Merck pulls out of a long-running collaboration

Endpoints

Thu, 10/8/20 - 11:03 am

Moderna Therapeutics

Why Seattle Genetics Stock Jumped 24% in September

Motley Fool

Wed, 10/7/20 - 10:44 am

Seattle Genetics

Occupied with immunology and cancer, Merck KGaA hands off osteoarthritis drug to Novartis for €50M cash

Endpoints

Tue, 10/6/20 - 11:26 pm

Foghorn blows its klaxon, gunning for a $100M IPO hot on the heels of its Merck deal

Fierce Biotech

Mon, 10/5/20 - 10:58 am

Foghorn Therapeutics

chromatin regulatory system

This Late-to-the-Party Coronavirus Vaccine Maker Could Be the Biggest Winner Over the Long Run

Motley Fool

Fri, 10/2/20 - 01:26 pm

Perlmutter steps down as Merck R&D lead as early research chief Li steps in

Fierce Biotech

Fri, 10/2/20 - 12:39 pm

Roger Perlmutter

Racing ahead of Merck and Innovent, Junshi declares PhIII success on cancer that won them 'breakthrough' status

Endpoints

Tue, 09/29/20 - 11:51 am

Junshi Biosciences

nasopharyngeal carcinoma

Drugmakers push forward on large-scale production of coronavirus vaccines

BioPharma Dive

Thu, 09/24/20 - 11:44 pm

Operation Warp Speed

Moderna Therapeutics

Here come the tortoises: In the race for a Covid-19 vaccine, slow starters could still win out

Stat

Thu, 09/24/20 - 10:39 am

Moderna Therapeutics

ALX Oncology Pairs Lead Asset with Keytruda in HNSCC Study

BioSpace

Tue, 09/22/20 - 12:06 pm

head and neck cancer

ESMO: Merck and AstraZeneca's 5-Year Lynparza Data in Ovarian Cancer and More

BioSpace

Sun, 09/20/20 - 08:00 pm

clinical tirals

ESMO: Roche's mixed results put Tecentriq's triple-negative breast cancer use into question

Fierce Pharma

Sun, 09/20/20 - 07:57 pm

triple negative breast cancer

Pages